title: Glutamate carboxypeptidase II and folate deficiencies result in reciprocal protection against cognitive and social deficits in mice: implications for neurodevelopmental disorders.
abstract: Interactions between genetic and environmental risk factors underlie a number of neuropsychiatric disorders, including schizophrenia (SZ) and autism (AD). Due to the complexity and multitude of the genetic and environmental factors attributed to these disorders, recent research strategies focus on elucidating the common molecular pathways through which these multiple risk factors may function. In this study, we examine the combined effects of a haplo-insufficiency of glutamate carboxypeptidase II (GCPII) and dietary folic acid deficiency. In addition to serving as a neuropeptidase, GCPII catalyzes the absorption of folate. GCPII and folate depletion interact within the one-carbon metabolic pathway and/or of modulate the glutamatergic system. Four groups of mice were tested: wild-type, GCPII hypomorphs, and wild-types and GCPII hypomorphs both fed a folate deficient diet. Due to sex differences in the prevalence of SZ and AD, both male and female mice were assessed on a number of behavioral tasks including locomotor activity, rotorod, social interaction, prepulse inhibition, and spatial memory. Wild-type mice of both sexes fed a folic acid deficient diet showed motor coordination impairments and cognitive deficits, while social interactions were decreased only in males. GCPII mutant mice of both sexes also exhibited reduced social propensities. In contrast, all folate-depleted GCPII hypomorphs performed similarly to untreated wild-type mice, suggesting that reduced GCPII expression and folate deficiency are mutually protective. Analyses of folate and neurometabolite levels associated with glutamatergic function suggest several potential mechanisms through which GCPII and folate may be interacting to create this protective effect.
authors.affiliation: Department of Biology, Tufts University, Medford, Massachusetts 02155, USA.
authors.forename: Laura R
authors.initials: LR
authors.lastname: Schaevitz
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Picker
authors.forename: Jasmine
authors.initials: J
authors.lastname: Rana
authors.forename: Nancy H
authors.initials: NH
authors.lastname: Kolodny
authors.forename: Barry
authors.initials: B
authors.lastname: Shane
authors.forename: Joanne E
authors.initials: JE
authors.lastname: Berger-Sweeney
authors.forename: Joseph T
authors.initials: JT
authors.lastname: Coyle
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000502:physiology*; D003072:Cognition Disorders / Q000235:genetics / Q000503:physiopathology*; D005260:Female; D005494:Folic Acid Deficiency / Q000503:physiopathology*; D059647:Gene-Environment Interaction; D043425:Glutamate Carboxypeptidase II / Q000235:genetics*; D057895:Haploinsufficiency; D008297:Male; D018782:Maze Learning / Q000502:physiology*; D051379:Mice; D008822:Mice, Transgenic; D009043:Motor Activity / Q000502:physiology; D045442:Rotarod Performance Test; D012919:Social Behavior
chemical_list: D043425:Glutamate Carboxypeptidase II
references.citation: Am J Hum Genet. 2008 Mar;82(3):696-711
references.pmid: 18319075
references.citation: J Alzheimers Dis. 2004 Jun;6(3):269-73
references.pmid: 15201481
references.citation: Proc Natl Acad Sci U S A. 1997 May 27;94(11):5923-8
references.pmid: 9159176
references.citation: J Nutr. 2008 Dec;138(12):2502-9
references.pmid: 19022979
references.citation: Behav Brain Res. 2005 Sep 8;163(2):265-76
references.pmid: 16039728
references.citation: Curr Med Chem Anticancer Agents. 2002 May;2(3):331-55
references.pmid: 12678736
references.citation: J Neurochem. 1999 Oct;73(4):1566-72
references.pmid: 10501202
references.citation: Med Hypotheses. 2008 Sep;71(3):406-10
references.pmid: 18514430
references.citation: Semin Reprod Med. 2009 Sep;27(5):351-7
references.pmid: 19711245
references.citation: Neuropsychopharmacology. 2008 Dec;33(13):3037-45
references.pmid: 17805313
references.citation: Neuropsychopharmacology. 2006 Sep;31(9):1880-7
references.pmid: 16395297
references.citation: Eur J Neurosci. 2000 Oct;12(10):3721-8
references.pmid: 11029642
references.citation: Neuron. 2006 Oct 5;52(1):139-53
references.pmid: 17015232
references.citation: Behav Pharmacol. 2009 Feb;20(1):56-66
references.pmid: 19179851
references.citation: Am J Clin Nutr. 2007 Aug;86(2):514-21
references.pmid: 17684227
references.citation: Neurobiol Dis. 2007 May;26(2):473-80
references.pmid: 17395475
references.citation: Schizophr Res. 2011 Apr;127(1-3):41-5
references.pmid: 21334854
references.citation: Vitam Horm. 1989;45:263-335
references.pmid: 2688305
references.citation: J Pharmacol Sci. 2008 Nov;108(3):227-38
references.pmid: 19008644
references.citation: Vitam Horm. 2008;79:1-44
references.pmid: 18804690
references.citation: NMR Biomed. 2009 Aug;22(7):737-44
references.pmid: 19338025
references.citation: Psychiatr Clin North Am. 2010 Mar;33(1):83-105
references.pmid: 20159341
references.citation: Clin Chem. 1988 Nov;34(11):2357-9
references.pmid: 3141087
references.citation: J Neurochem. 2009 Jan;108(2):361-71
references.pmid: 19012748
references.citation: Hum Mol Genet. 2000 Nov 22;9(19):2837-44
references.pmid: 11092759
references.citation: Psychother Psychosom. 2003 Mar-Apr;72(2):80-7
references.pmid: 12601225
references.citation: Hum Mol Genet. 2006 Dec 1;15(23):3387-93
references.pmid: 17050573
references.citation: Eur J Clin Nutr. 2011 Dec;65(12):1302-8
references.pmid: 21731042
references.citation: FASEB J. 2010 Aug;24(8):3036-51
references.pmid: 20375269
references.citation: J Biol Chem. 1998 Aug 7;273(32):20417-24
references.pmid: 9685395
references.citation: Theor Biol Med Model. 2008 Apr 28;5:8
references.pmid: 18442411
references.citation: J Neurochem. 1997 Jul;69(1):174-81
references.pmid: 9202308
references.citation: J Neurosci. 2008 Jul 9;28(28):7219-30
references.pmid: 18614692
references.citation: Brain Res. 1998 Jun 8;795(1-2):341-8
references.pmid: 9622670
references.citation: J Biol Chem. 2009 Jan 16;284(3):1533-9
references.pmid: 19033438
references.citation: Epidemiology. 2011 Sep;22(5):731-7
references.pmid: 21659881
references.citation: Am J Clin Nutr. 2000 Feb;71(2):614S-620S
references.pmid: 10681269
references.citation: Schizophr Res. 2009 Jun;111(1-3):131-7
references.pmid: 19403271
references.citation: Neurobiol Dis. 1997;4(3-4):231-8
references.pmid: 9361299
references.citation: Hum Mol Genet. 2001 Mar 1;10(5):433-43
references.pmid: 11181567
references.citation: Br J Nutr. 2007 Jun;97(6):1090-8
references.pmid: 17433124
references.citation: Mol Aspects Med. 2009 Feb-Apr;30(1-2):42-59
references.pmid: 18601945
references.citation: Biol Psychiatry. 2010 Aug 15;68(4):314-9
references.pmid: 20674602
references.citation: Brain Res. 2011 Jan 31;1371:82-6
references.pmid: 21093418
references.citation: Physiol Behav. 1995 Nov;58(5):935-41
references.pmid: 8577891
references.citation: Genes Brain Behav. 2004 Oct;3(5):287-302
references.pmid: 15344922
references.citation: Pharmacol Ther. 2008 Dec;120(3):317-32
references.pmid: 18805436
references.citation: Neuroscience. 2011 Mar 10;176:336-48
references.pmid: 21193020
references.citation: J Neurochem. 1994 Nov;63(5):1714-9
references.pmid: 7523599
references.citation: NMR Biomed. 2011 Dec;24(10):1235-42
references.pmid: 21560175
references.citation: Arch Gen Psychiatry. 1995 Oct;52(10):829-36
references.pmid: 7575102
references.citation: Lancet. 1998 Oct 3;352(9134):1120-1
references.pmid: 9798595
references.citation: Schizophr Bull. 2011 Mar;37(2):272-83
references.pmid: 20974747
references.citation: Trends Mol Med. 2009 Dec;15(12):562-70
references.pmid: 19896901
references.citation: Nutr Res Rev. 2006 Jun;19(1):117-36
references.pmid: 19079880
references.citation: J Neurochem. 2005 Sep;94(6):1594-603
references.pmid: 16045441
references.citation: Neurotoxicology. 2008 Jan;29(1):190-201
references.pmid: 18031821
references.citation: Schizophr Res. 2008 Feb;99(1-3):324-32
references.pmid: 18191545
references.citation: Synapse. 2009 Aug;63(8):625-35
references.pmid: 19347959
references.citation: Harv Rev Psychiatry. 2005 Jul-Aug;13(4):197-205
references.pmid: 16126606
references.citation: Epidemiology. 2011 Jul;22(4):476-85
references.pmid: 21610500
references.citation: Med Hypotheses. 2011 Jul;77(1):15-7
references.pmid: 21454018
references.citation: J Chromatogr. 1987 Nov 27;422:43-52
references.pmid: 3437026
references.citation: J Neurosci Res. 2004 Feb 15;75(4):508-15
references.pmid: 14743434
references.citation: Mol Genet Metab. 2011 Nov;104(3):369-72
references.pmid: 21737328
references.citation: J Comp Neurol. 1999 Dec 6;415(1):52-64
references.pmid: 10540357
references.citation: Am J Med Genet B Neuropsychiatr Genet. 2006 Dec 5;141B(8):947-56
references.pmid: 16917939
references.citation: Curr Genomics. 2010 Sep;11(6):447-69
references.pmid: 21358990
references.citation: Nutr Res Pract. 2009 Spring;3(1):43-8
references.pmid: 20016701